202 related articles for article (PubMed ID: 25037814)
21. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
Fernandes NF; Rosenbach M; Elenitsas R; Kist JM
Arch Dermatol; 2009 Mar; 145(3):340-1. PubMed ID: 19289781
[No Abstract] [Full Text] [Related]
22. Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine.
Weger W; Kränke B; Gerger A; Salmhofer W; Aberer E
J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S4-6. PubMed ID: 18625380
[TBL] [Abstract][Full Text] [Related]
23. Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine.
Villalón G; Martín JM; Pinazo MI; Calduch L; Alonso V; Jordá E
Am J Clin Dermatol; 2009; 10(4):261-3. PubMed ID: 19489659
[TBL] [Abstract][Full Text] [Related]
24. Severe hypertriglyceridaemia associated with the use of capecitabine.
Polinder-Bos HA; Kok EE; van de Wiel A; Spiering W; Wielders JP; Bloemendal HJ
Neth J Med; 2012 Mar; 70(2):104. PubMed ID: 22418760
[No Abstract] [Full Text] [Related]
25. [Myocardial ischaemia as a result of treatment with capecitabine].
van der Vliet HJ; Kuenen BC
Ned Tijdschr Geneeskd; 2007 Sep; 151(36):2016; author reply 2016. PubMed ID: 17953177
[No Abstract] [Full Text] [Related]
26. Liver injury possibly related to drug interaction after liver transplant: a case report.
Zhu LQ; Jiang WT; Pan C; Liu YH; Thian Y
J Clin Pharm Ther; 2014 Aug; 39(4):439-41. PubMed ID: 24661191
[TBL] [Abstract][Full Text] [Related]
27. Granulomatous septal panniculitis associated with capecitabine (Xeloda).
Dalmau J; Roé E; Puig L; Alomar A
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):121-2. PubMed ID: 18181993
[No Abstract] [Full Text] [Related]
28. [Acute coronary syndrome during oral capecitabine monotherapy].
Martí V; Monell J; Seixo F; Falces C
Rev Esp Cardiol; 2008 May; 61(5):548-9. PubMed ID: 18462663
[No Abstract] [Full Text] [Related]
29. Capecitabine-induced subacute cutaneous lupus erythematosus: report of a case with positive rechallenge test.
Ko JH; Hsieh CI; Chou CY; Wang KH
J Dermatol; 2013 Nov; 40(11):939-40. PubMed ID: 24111883
[No Abstract] [Full Text] [Related]
30. Capecitabine induced inflammation of actinic keratoses.
Krathen M; Treat J; James WD
Dermatol Online J; 2007 Oct; 13(4):13. PubMed ID: 18319010
[TBL] [Abstract][Full Text] [Related]
31. Discoid lupus erythematosus (DLE)-like lesions induced by capecitabine.
Merlin F; Prochilo T; Kildani B; Lombardi C; Pasolini G; Bonetti F; Beretta GD
Int J Colorectal Dis; 2008 Jul; 23(7):715-6. PubMed ID: 18330579
[No Abstract] [Full Text] [Related]
32. Lichenoid photosensitivity: an unusual reaction to doxycycline and an unusual response.
Susong J; Carrizales S
Cutis; 2014 May; 93(5):E1-2. PubMed ID: 24897144
[No Abstract] [Full Text] [Related]
33. Capecitabine-induced acute myeloid leukaemia.
Tansley S; Gibbons S
N Z Med J; 2009 May; 122(1294):118-9. PubMed ID: 19465957
[No Abstract] [Full Text] [Related]
34. Severe hypertriglyceridaemia during treatment with capecitabine.
Javot L; Spaëth D; Scala-Bertola J; Gambier N; Petitpain N; Gillet P
Br J Cancer; 2011 Mar; 104(7):1238-9. PubMed ID: 21386842
[No Abstract] [Full Text] [Related]
35. Standard-dose tegafur combined with uracil is not safe treatment after severe toxicity from 5-fluorouracil or capecitabine.
Deenen MJ; Terpstra WE; Cats A; Boot H; Schellens JH
Ann Intern Med; 2010 Dec; 153(11):767-8. PubMed ID: 21135311
[No Abstract] [Full Text] [Related]
36. Exudative, nonhealing scalp: a complication of systemic chemotherapy with capecitabine and bevacizumab.
Black JM; Hodari KT; Rogers N; Farris PK; Lewis AT; Boh EE
Arch Dermatol; 2011 Jan; 147(1):134-5. PubMed ID: 21242416
[No Abstract] [Full Text] [Related]
37. Safety of capecitabine use in patients with liver dysfunction.
Saif MW; Tejani MA
Clin Adv Hematol Oncol; 2007 Sep; 5(9):730-2; discussion 736. PubMed ID: 17982413
[No Abstract] [Full Text] [Related]
38. Longitudinal melanonychia induced by capecitabine.
Paravar T; Hymes SR
Dermatol Online J; 2009 Oct; 15(10):11. PubMed ID: 19951629
[TBL] [Abstract][Full Text] [Related]
39. Severe or lethal toxicities upon capecitabine intake: is DPYD genetic polymorphism the ideal culprit?
Mercier C; Ciccolini J
Trends Pharmacol Sci; 2007 Dec; 28(12):597-8. PubMed ID: 18001850
[No Abstract] [Full Text] [Related]
40. Capecitabine-induced coronary vasospasm.
Goldsmith YB; Roistacher N; Baum MS
J Clin Oncol; 2008 Aug; 26(22):3802-4. PubMed ID: 18669470
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
